Cargando…

Improving immunological tumor microenvironment using electro-hyperthermia followed by dendritic cell immunotherapy

BACKGROUND: The treatment of intratumoral dentritic cells (DCs) commonly fails because it cannot evoke immunity in a poor tumor microenvironment (TME). Modulated electro-hyperthermia (mEHT, trade-name: oncothermia) represents a significant technological advancement in the hyperthermia field, allowin...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsang, Yuk-Wah, Huang, Cheng-Chung, Yang, Kai-Lin, Chi, Mau-Shin, Chiang, Hsin-Chien, Wang, Yu-Shan, Andocs, Gabor, Szasz, Andras, Li, Wen-Tyng, Chi, Kwan-Hwa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608323/
https://www.ncbi.nlm.nih.gov/pubmed/26472466
http://dx.doi.org/10.1186/s12885-015-1690-2
_version_ 1782395653162270720
author Tsang, Yuk-Wah
Huang, Cheng-Chung
Yang, Kai-Lin
Chi, Mau-Shin
Chiang, Hsin-Chien
Wang, Yu-Shan
Andocs, Gabor
Szasz, Andras
Li, Wen-Tyng
Chi, Kwan-Hwa
author_facet Tsang, Yuk-Wah
Huang, Cheng-Chung
Yang, Kai-Lin
Chi, Mau-Shin
Chiang, Hsin-Chien
Wang, Yu-Shan
Andocs, Gabor
Szasz, Andras
Li, Wen-Tyng
Chi, Kwan-Hwa
author_sort Tsang, Yuk-Wah
collection PubMed
description BACKGROUND: The treatment of intratumoral dentritic cells (DCs) commonly fails because it cannot evoke immunity in a poor tumor microenvironment (TME). Modulated electro-hyperthermia (mEHT, trade-name: oncothermia) represents a significant technological advancement in the hyperthermia field, allowing the autofocusing of electromagnetic power on a cell membrane to generate massive apoptosis. This approach turns local immunogenic cancer cell death (apoptosis) into a systemic anti-tumor immune response and may be implemented by treatment with intratumoral DCs. METHODS: The CT26 murine colorectal cancer model was used in this investigation. The inhibition of growth of the tumor and the systemic anti-tumor immune response were measured. The tumor was heated to a core temperature of 42 °C for 30 min. The matured synergetic DCs were intratumorally injected 24 h following mEHT was applied. RESULTS: mEHT induced significant apoptosis and enhanced the release of heat shock protein70 (Hsp70) in CT26 tumors. Treatment with mEHT-DCs significantly inhibited CT26 tumor growth, relative to DCs alone or mEHT alone. The secondary tumor protection effect upon rechallenging was observed in mice that were treated with mEHT-DCs. Immunohistochemical staining of CD45 and F4/80 revealed that mEHT-DC treatment increased the number of leukocytes and macrophages. Most interestingly, mEHT also induced infiltrations of eosinophil, which has recently been reported to be an orchestrator of a specific T cell response. Cytotoxic T cell assay and ELISpot assay revealed a tumor-specific T cell activity. CONCLUSIONS: This study demonstrated that mEHT induces tumor cell apoptosis and enhances the release of Hsp70 from heated tumor cells, unlike conventional hyperthermia. mEHT can create a favorable tumor microenvironment for an immunological chain reaction that improves the success rate of intratumoral DC immunotherapy. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-015-1690-2) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4608323
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46083232015-10-17 Improving immunological tumor microenvironment using electro-hyperthermia followed by dendritic cell immunotherapy Tsang, Yuk-Wah Huang, Cheng-Chung Yang, Kai-Lin Chi, Mau-Shin Chiang, Hsin-Chien Wang, Yu-Shan Andocs, Gabor Szasz, Andras Li, Wen-Tyng Chi, Kwan-Hwa BMC Cancer Research Article BACKGROUND: The treatment of intratumoral dentritic cells (DCs) commonly fails because it cannot evoke immunity in a poor tumor microenvironment (TME). Modulated electro-hyperthermia (mEHT, trade-name: oncothermia) represents a significant technological advancement in the hyperthermia field, allowing the autofocusing of electromagnetic power on a cell membrane to generate massive apoptosis. This approach turns local immunogenic cancer cell death (apoptosis) into a systemic anti-tumor immune response and may be implemented by treatment with intratumoral DCs. METHODS: The CT26 murine colorectal cancer model was used in this investigation. The inhibition of growth of the tumor and the systemic anti-tumor immune response were measured. The tumor was heated to a core temperature of 42 °C for 30 min. The matured synergetic DCs were intratumorally injected 24 h following mEHT was applied. RESULTS: mEHT induced significant apoptosis and enhanced the release of heat shock protein70 (Hsp70) in CT26 tumors. Treatment with mEHT-DCs significantly inhibited CT26 tumor growth, relative to DCs alone or mEHT alone. The secondary tumor protection effect upon rechallenging was observed in mice that were treated with mEHT-DCs. Immunohistochemical staining of CD45 and F4/80 revealed that mEHT-DC treatment increased the number of leukocytes and macrophages. Most interestingly, mEHT also induced infiltrations of eosinophil, which has recently been reported to be an orchestrator of a specific T cell response. Cytotoxic T cell assay and ELISpot assay revealed a tumor-specific T cell activity. CONCLUSIONS: This study demonstrated that mEHT induces tumor cell apoptosis and enhances the release of Hsp70 from heated tumor cells, unlike conventional hyperthermia. mEHT can create a favorable tumor microenvironment for an immunological chain reaction that improves the success rate of intratumoral DC immunotherapy. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-015-1690-2) contains supplementary material, which is available to authorized users. BioMed Central 2015-10-15 /pmc/articles/PMC4608323/ /pubmed/26472466 http://dx.doi.org/10.1186/s12885-015-1690-2 Text en © Tsang et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Tsang, Yuk-Wah
Huang, Cheng-Chung
Yang, Kai-Lin
Chi, Mau-Shin
Chiang, Hsin-Chien
Wang, Yu-Shan
Andocs, Gabor
Szasz, Andras
Li, Wen-Tyng
Chi, Kwan-Hwa
Improving immunological tumor microenvironment using electro-hyperthermia followed by dendritic cell immunotherapy
title Improving immunological tumor microenvironment using electro-hyperthermia followed by dendritic cell immunotherapy
title_full Improving immunological tumor microenvironment using electro-hyperthermia followed by dendritic cell immunotherapy
title_fullStr Improving immunological tumor microenvironment using electro-hyperthermia followed by dendritic cell immunotherapy
title_full_unstemmed Improving immunological tumor microenvironment using electro-hyperthermia followed by dendritic cell immunotherapy
title_short Improving immunological tumor microenvironment using electro-hyperthermia followed by dendritic cell immunotherapy
title_sort improving immunological tumor microenvironment using electro-hyperthermia followed by dendritic cell immunotherapy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608323/
https://www.ncbi.nlm.nih.gov/pubmed/26472466
http://dx.doi.org/10.1186/s12885-015-1690-2
work_keys_str_mv AT tsangyukwah improvingimmunologicaltumormicroenvironmentusingelectrohyperthermiafollowedbydendriticcellimmunotherapy
AT huangchengchung improvingimmunologicaltumormicroenvironmentusingelectrohyperthermiafollowedbydendriticcellimmunotherapy
AT yangkailin improvingimmunologicaltumormicroenvironmentusingelectrohyperthermiafollowedbydendriticcellimmunotherapy
AT chimaushin improvingimmunologicaltumormicroenvironmentusingelectrohyperthermiafollowedbydendriticcellimmunotherapy
AT chianghsinchien improvingimmunologicaltumormicroenvironmentusingelectrohyperthermiafollowedbydendriticcellimmunotherapy
AT wangyushan improvingimmunologicaltumormicroenvironmentusingelectrohyperthermiafollowedbydendriticcellimmunotherapy
AT andocsgabor improvingimmunologicaltumormicroenvironmentusingelectrohyperthermiafollowedbydendriticcellimmunotherapy
AT szaszandras improvingimmunologicaltumormicroenvironmentusingelectrohyperthermiafollowedbydendriticcellimmunotherapy
AT liwentyng improvingimmunologicaltumormicroenvironmentusingelectrohyperthermiafollowedbydendriticcellimmunotherapy
AT chikwanhwa improvingimmunologicaltumormicroenvironmentusingelectrohyperthermiafollowedbydendriticcellimmunotherapy